Attached files
file | filename |
---|---|
8-K - FORM 8-K - IRIS INTERNATIONAL INC | c12608e8vk.htm |
EX-10.1 - EXHIBIT 10.1 - IRIS INTERNATIONAL INC | c12608exv10w1.htm |
Exhibit 99.1
NEWS RELEASE
CONTACTS:
|
César M. García, | |
Chairman and Chief Executive Officer | ||
IRIS International, Inc. | ||
818-527-7000 | ||
-or- | ||
Ron Stabiner, The Wall Street Group, Inc. | ||
212-888-4848 |
FOR IMMEDIATE RELEASE:
IRIS International Appoints Dr. Richard A. OLeary as Corporate Vice President,
Human Resources and Administration
Brings More Than 27 Years of Human Resource Leadership Experience With Multi-billion Dollar Companies
Human Resources and Administration
Brings More Than 27 Years of Human Resource Leadership Experience With Multi-billion Dollar Companies
CHATSWORTH, Calif., February 15, 2010 IRIS International, Inc. (NASDAQ GM: IRIS), a leading
manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and
commercial laboratories worldwide, and a provider of high value personalized diagnostics testing
services through its CLIA certified molecular diagnostics laboratory, today announced that it has
appointed Dr. Richard A. OLeary to the newly created position of Corporate Vice President, Human
Resources and Administration, effective February 14, 2011. Dr. OLeary joins IRIS with some 27
years of senior executive human resources and corporate management experience, having served with
such companies as Corning Incorporated, Cytometrics, Owens Corning, and Public Service Electric &
Gas (PSE&G). Reporting directly to César M. García, Chairman, President and Chief Executive
Officer of IRIS, Dr. OLeary will oversee all human resource functions for the Companys domestic
and international operations with responsibility for the planning and implementation of key human
resource initiatives, as well as improved integration across each of the Companys business units.
Dr. OLeary brings to this new position at IRIS a wealth of experience with large international
companies and adds an important skill set to our senior management team at a time when IRIS, with
some 375 employees worldwide and growing, is poised for continued growth in its profitable core
business while also expanding into new business opportunities. Dr. OLearys experience with
diagnostics and high technology companies, and his proven global human resource experience and
extensive track record in business integration and the implementation of leadership and
organizational development programs, will play an important role as we continue our expansion
program. We look forward to his contributions and leadership as a key member of our senior
executive team, said Mr. García.
IRIS at this point in its corporate development has developed a rich management style of
intellect, creativity, diversity and collegiality, and a group of senior executives who take
seriously the task of mentoring newer and often younger associates. With its dominant core position
in urinalysis worldwide and its pipeline of new product opportunities, the need for effective human
resources strategies and effective pay for performance programs throughout the organization becomes
an important part of the business and an exciting opportunity for me, said Dr. OLeary. I look
forward to contributing to and participating in the continuing growth of IRIS and am pleased at the
opportunity.
Dr. OLeary, since 2001, was with Corning Incorporated (NYSE: GLW), the world leader in specialty
glass and ceramics, where since January 2009 he served as Global Director Human Resources,
International Regions and, prior to that, as Director of Human Resources, Development, Engineering
and Legal. Prior to Corning, from 19972001, he was Vice President, Human Resources of
Cytometrics, Inc., a privately held medical device company. Before that, from 19951997, he was
Director, Leadership Development & Organizational Effectiveness for Owens Corning (NYSE: OC), a
multi-national corporation with revenue of more than $5 billion. In addition, Dr, OLeary held
several senior human resource and/or senior executive positions at Public Service Electric & Gas
(PSE&G), Devereaux Foundation and Health Management Systems, and Health Circle, a Blue Cross HMO servicing more than 35,000 members. Since 1987, Dr. OLeary has served in the Delaware
Air National Guard, where he is currently Human Relations Officer and Lieutenant Colonel of the
United States Air Force.
He is also a member of the Adjunct Faculty Family Practice of the University of Medicine &
Dentistry of New Jersey- School of Osteopathic Medicine. He is the recipient of numerous awards
including the Western Michigan University Distinguished Alumni Award and the Corning, Inc.
Presidents Excellence Award. Dr. OLeary earned a Doctor of Education degree from Western
Michigan University, and a Master of Education and Bachelor of Arts from the University of
Delaware.
About IRIS International
IRIS International, Inc. is a leading global in vitro diagnostics company focused on products that
analyze particles and living cell forms and structures, or morphology of a variety of body fluids.
The Companys products leverage its strengths in flow imaging technology, particle recognition and
automation to bring efficiency to hospital and commercial laboratories. The initial applications
for its technology have been in the urinalysis market and the Company is the leading worldwide
provider of automated urine microscopy and chemistry systems, with an installed base of more than
3.000 systems in more than 50 countries. The Company is expanding its core imaging and morphology
expertise into related markets and is developing applications in hematology and urinary tract
infections. In addition, the Company recently acquired a high complexity CLIA-certified molecular
pathology laboratory offering differentiated, high value molecular diagnostic services in the
rapidly growing field of personalized medicine. The laboratory provides a direct commercial channel
for the Companys NADiA® ultra-sensitive nucleic acid detection immunoassay platform,
with applications in oncology and infectious disease. For more information, please visit
www.proiris.com.
# # #